Effects of polycythemia on systemic endothelial function in chronic hypoxic lung disease

Journal of Applied Physiology

Volumn 110, Issue 5, 2011, Pages 1196-1203

  Boyer, Laurent ^a,b   Chaar, Vicky ^b   Pelle, Gabriel ^a,b   Maitre, Bernard ^b,c   Chouaid, Christos ^d   Covali Noroc, Ala ^a   Zerah, Françoise ^a   Bucherer, Catherine ^a   Lacombe, Catherine ^a   Housset, Bruno ^b,c   Dubois Randé, Jean Luc ^a,b   Boczkowski, Jorge ^b,c   Adnot, Serge ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b INSERM U955   (France)

^c CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^d HÔPITAL SAINT ANTOINE   (France)

Author keywords

Chronic obstructive pulmonary disease; Endothelium

Indexed keywords

EID: 79956124167     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01204.2010     Document Type: Article

References (32)

1. Belhassen L, Pelle G, Dubois-Rande JL, Adnot S. Improved endothelial function by the thromboxane A2 receptor antagonist S 18886 in patients with coronary artery disease treated with aspirin. J Am Coll Cardiol 41: 1198-1204, 2003. (Pubitemid 36384909)
2. Belhassen L, Pelle G, Sediame S, Bachir D, Carville C, Bucherer C, Lacombe C, Galacteros F, Adnot S. Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stressmediated vasodilation. Blood 97: 1584-1589, 2001. (Pubitemid 32217221)
3. Brodde OE, Konschak U, Becker K, Ruter F, Poller U, Jakubetz J, Radke J, Zerkowski HR. Cardiac muscarinic receptors decrease with age. In vitro and in vivo studies. J Clin Invest 101: 471-478, 1998. (Pubitemid 28067345)
4. Buick FJ, Gledhill N, Froese AB, Spriet L, Meyers EC. Effect of induced erythrocythemia on aerobic work capacity. J Appl Physiol 48: 636-642, 1980. (Pubitemid 10109147)
5. Busse R, Fleming I, Hecker M. Signal transduction in endotheliumdependent vasodilatation. Eur Heart J 14, Suppl I: 2-9, 1993.
6. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356: 775-789, 2007. (Pubitemid 46294610)
7. Casino PR, Kilcoyne CM, Cannon RO 3rd, Quyyumi AA, Panza JA. Impaired endothelium-dependent vascular relaxation in patients with hypercholesterolemia extends beyond the muscarinic receptor. Am J Cardiol 75: 40-44, 1995.
8. Chambellan A, Chailleux E, Similowski T. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 128: 1201-1208, 2005. (Pubitemid 41324396)
9. Chetty KG, Light RW, Stansbury DW, Milne N. Exercise performance of polycythemic chronic obstructive pulmonary disease patients. Effect of phlebotomies. Chest 98: 1073-1077, 1990. (Pubitemid 20381263)
10. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev 75: 519-560, 1995.
11. Defouilloy C, Teiger E, Sediame S, Andrivet P, Roudot-Thoraval F, Chouaid C, Housset B, Adnot S. Polycythemia impairs vasodilator response to acetylcholine in patients with chronic hypoxemic lung disease. Am J Respir Crit Care Med 157: 1452-1460, 1998.
12. DeSouza CA, Clevenger CM, Greiner JJ, Smith DT, Hoetzer GL, Shapiro LF, Stauffer BL. Evidence for agonist-specific endothelial vasodilator dysfunction with ageing in healthy humans. J Physiol 542: 255-262, 2002. (Pubitemid 35190287)
13. Faeh D, Gutzwiller F, Bopp M. Lower mortality from coronary heart disease and stroke at higher altitudes in Switzerland. Circulation 120: 495-501, 2009.
14. Fyfe A, Perloff JK, Niwa K, Child JS, Miner PD. Cyanotic congenital heart disease and coronary artery atherogenesis. Am J Cardiol 96: 283-290, 2005. (Pubitemid 40978590)
15. Giannattasio C, Piperno A, Failla M, Vergani A, Mancia G. Effects of hematocrit changes on flow-mediated and metabolic vasodilation in humans. Hypertension 40: 74-77, 2002. (Pubitemid 34755982)
16. Gladwin MT, Schechter AN, Ognibene FP, Coles WA, Reiter CD, Schenke WH, Csako G, Waclawiw MA, Panza JA, Cannon RO 3rd. Divergent nitric oxide bioavailability in men and women with sickle cell disease. Circulation 107: 271-278, 2003. (Pubitemid 36135223)
17. Hirooka Y, Imaizumi T, Harada S, Masaki H, Momohara M, Tagawa T, Takeshita A. Endothelium-dependent forearm vasodilation to acetylcholine but not to substance P is impaired in patients with heart failure. J Cardiovasc Pharmacol 20, Suppl 12: S221-S225, 1992. (Pubitemid 23014154)
18. Humphrey PR, Du Boulay GH, Marshall J, Pearson TC, Russell RW, Symon L, Wetherley-Mein G, Zilkha E. Cerebral blood-flow and viscosity in relative polycythaemia. Lancet 2: 873-877, 1979.
19. Langille BL, O'Donnell F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 231: 405-407, 1986. (Pubitemid 16108652)
20. Martini J, Carpentier B, Negrete AC, Frangos JA, Intaglietta M. Paradoxical hypotension following increased hematocrit and blood viscosity. Am J Physiol Heart Circ Physiol 289: H2136-H2143, 2005. (Pubitemid 41507366)
21. Neunteufl T, Heher S, Stefenelli T, Pabinger I, Gisslinger H. Endothelial dysfunction in patients with polycythaemia vera. Br J Haematol 115: 354-359, 2001. (Pubitemid 34203502)
22. Oechslin E, Kiowski W, Schindler R, Bernheim A, Julius B, Brunner-La Rocca HP. Systemic endothelial dysfunction in adults with cyanotic congenital heart disease. Circulation 112: 1106-1112, 2005. (Pubitemid 41216116)
23. + current in vascular endothelial cells. Nature 331: 168-170, 1988. (Pubitemid 18042148)
24. Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, Sessa WC. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 101: 731-736, 1998. (Pubitemid 28096068)
25. Ruschitzka FT, Wenger RH, Stallmach T, Quaschning T, de Wit C, Wagner K, Labugger R, Kelm M, Noll G, Rulicke T, Shaw S, Lindberg RL, Rodenwaldt B, Lutz H, Bauer C, Luscher TF, Gassmann M. Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci USA 97: 11609-11613, 2000.
26. Salazar Vazquez BY, Martini J, Chavez Negrete A, Tsai AG, Forconi S, Cabrales P, Johnson PC, Intaglietta M. Cardiovascular benefits in moderate increases of blood and plasma viscosity surpass those associated with lowering viscosity: experimental and clinical evidence. Clin Hemorheol Microcirc 44: 75-85, 2010.
27. Savale L, Chaouat A, Bastuji-Garin S, Marcos E, Boyer L, Maitre B, Sarni M, Housset B, Weitzenblum E, Matrat M, Le Corvoisier P, Rideau D, Boczkowski J, Dubois-Rande JL, Chouaid C, Adnot S. Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 179: 566-571, 2009.
28. Schuler B, Arras M, Keller S, Rettich A, Lundby C, Vogel J, Gassmann M. Optimal hematocrit for maximal exercise performance in acute and chronic erythropoietin-treated mice. Proc Natl Acad Sci USA 107: 419-423, 2010.
29. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 107: 1514-1519, 2003. (Pubitemid 36378490)
30. Wautier MP, El Nemer W, Gane P, Rain JD, Cartron JP, Colin Y, Le Van Kim C, Wautier JL. Increased adhesion to endothelial cells of erythrocytes from patients with polycythemia vera is mediated by laminin alpha5 chain and Lu/BCAM. Blood 110: 894-901, 2007. (Pubitemid 47267426)
31. Yates CJ, Berent A, Andrews V, Dormandy JA. Increase in leg blood-flow by normovolaemic haemodilution in intermittent claudication. Lancet 2: 166-168, 1979. (Pubitemid 9222163)
32. York EL, Jones RL, Menon D, Sproule BJ. Effects of secondary polycythemia on cerebral blood flow in chronic obstructive pulmonary disease. Am Rev Respir Dis 121: 813-818, 1980. (Pubitemid 10096713)